Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy

Background: Spinal muscular atrophy (SMA) is a genetic disorder that leads to progressive tetraparesis. Nusinersen is the first approved drug for the treatment of SMA and is administered via intrathecal injections. Neuromyopathic scoliosis and spondylodesis can impede lumbar punctures, thus necessit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizina, Kathrin, Stolte, Benjamin, Totzeck, Andreas, Bolz, Saskia, Fleischer, Michael, Mönninghoff, Christoph, Guberina, Nika, Oldenburg, Denise, Forsting, Michael, Kleinschnitz, Christoph, Hagenacker, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856637/
https://www.ncbi.nlm.nih.gov/pubmed/31787921
http://dx.doi.org/10.3389/fneur.2019.01166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856637/
https://www.ncbi.nlm.nih.gov/pubmed/31787921
http://dx.doi.org/10.3389/fneur.2019.01166

Ejemplares similares